About Careers MedBlog Contact us

Cytomegalovirus: Reactivation Of This Virus Can Be Prevented After Stem Cell Transplantation

by Rishika Gupta on January 19, 2019 at 2:26 PM
Font : A-A+

 Cytomegalovirus: Reactivation Of This Virus Can Be Prevented After Stem Cell Transplantation

To prevent the reactivation of Cytomegalovirus in stem cell transplant recipient, a technique suggested by researchers can be used.

In a mouse model, researchers have identified a potential pathway towards creating effective treatments for Cytomegalovirus, a common, yet potentially lethal viral infection for stem cell transplant patients.


The results define the mechanisms that allow the insidious virus to re-awaken after periods of dormancy and identify a readily translatable strategy for developing new clinical approaches.

Cytomegalovirus (CMV) is a nearly ubiquitous herpes-type virus present in some estimated 60-90% of healthy adults. Like other herpesviruses, CMV can become dormant and remain in the body without effect until reactivating at a later time. For most of those who test positive for the virus, CMV is nothing to worry about - infections are mild and are kept in check by the immune system. However, for heavily immunosuppressed individuals, like patients recovering from bone marrow or hematopoietic stem cell transplantations (BMT), CMV infection and reactivation can be deadly.

Despite its association with significantly reduced survival following transplantations, the development of effective vaccines and antiviral therapies for CMV has been largely unsuccessful. Limited by toxicity and emergent drug-resistant strains, current therapies have been aimed toward mitigating, rather than preventing CMV disease.

Furthermore, preclinical animal models capable of reproducing CMV reactivation after a period of latency have been insufficient thus far. To address this need, Jose Martins and colleagues developed a preclinical mouse model that represented reactivation following BMT and discovered the crucial role humoral immunity plays in keeping CMV dormant.

According to Martins et al., reactivation of CMV could be prevented by passively administering immune serum containing antibodies matched to the infecting viral strain. The serum replaced dwindling antiviral antibodies, which were not being replaced by the donor B cells, and it does thus keep viral reactivation at bay. In a related Perspective, Maria-Luisa Alegre discusses the implications of this study in greater detail.

Source: Eurekalert


Recommended Reading

Latest Research News

Potential New Strategy for Ischemic Stroke Discovered
additive neuroprotection of a combination of two omega-3 fatty acid-derived signaling molecules is more effective in protecting brain cells.
Is Speech Therapy the Answer to Voice Problems in Parkinson's Disease Patients
Speech and voice disorders are common in individuals with Parkinson's disease.
 New Insights into How the Immune System Responds to Spinal-Cord Injuries
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune Diseases Affect One in Ten: Study
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Cytomegalovirus: Reactivation Of This Virus Can Be Prevented After Stem Cell Transplantation Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests